These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3629545)

  • 1. Plasma-dependent and -independent mechanisms of platelet aggregation induced by human tumour cell lines.
    Scarlett JD; Thurlow PJ; Connellan JM; Louis CJ
    Thromb Res; 1987 Jun; 46(5):715-26. PubMed ID: 3629545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of platelet aggregation induced by human colon adenocarcinoma cells and its inhibition by snake venom peptides, trigramin and rhodostomin.
    Chiang HS; Swaim MW; Huang TF
    Br J Haematol; 1994 Jun; 87(2):325-31. PubMed ID: 7947275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triflavin, an Arg-Gly-Asp containing snake venom peptide, inhibits aggregation of human platelets induced by human hepatoma cell line.
    Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
    Thromb Res; 1992 Jun; 66(6):679-91. PubMed ID: 1519227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Arg-Gly-Asp-containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by saos-2 human osteosarcoma cells.
    Chiang HS; Yang RS; Huang TF
    Br J Cancer; 1995 Feb; 71(2):265-70. PubMed ID: 7841039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits tumor cell-induced platelet aggregation.
    Sheu JR; Lin CH; Peng HC; Teng CM; Huang TF
    Jpn J Cancer Res; 1993 Oct; 84(10):1062-71. PubMed ID: 8226281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of platelet aggregation induced by PC-3 human prostate adenocarcinoma cells and inhibited by venom peptides, trigramin and rhodostomin.
    Swaim MW; Chiang HS; Huang TF
    Eur J Cancer; 1996 Apr; 32A(4):715-21. PubMed ID: 8695278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor cell-induced platelet aggregation in vitro by human pancreatic cancer cell lines.
    Heinmöller E; Schropp T; Kisker O; Simon B; Seitz R; Weinel RJ
    Scand J Gastroenterol; 1995 Oct; 30(10):1008-16. PubMed ID: 8545606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differing platelet aggregating effects by two tumor cell lines: absence of role for platelet-derived ADP.
    Bastida E; Ordinas A; Jamieson GA
    Am J Hematol; 1981 Dec; 11(4):367-78. PubMed ID: 7331992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of platelet activation by cultured human cancer cells and cells freshly isolated from tumor tissues.
    Grignani G; Pacchiarini L; Ricetti MM; Dionigi P; Jemos V; Zucchella M; Fratino P
    Invasion Metastasis; 1989; 9(5):298-309. PubMed ID: 2767927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet aggregating activity mediated by thrombin generation in the NCG human neuroblastoma cell line.
    Esumi N; Todo S; Imashuku S
    Cancer Res; 1987 Apr; 47(8):2129-35. PubMed ID: 3829002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformed rat arterial smooth muscle cells induce platelet aggregation.
    Blaes N; Covacho C
    Atherosclerosis; 1994 Oct; 110(2):163-74. PubMed ID: 7848366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors responsible for ADP-induced release reaction of human platelets.
    Mustard JF; Perry DW; Kinlough-Rathbone RL; Packham MA
    Am J Physiol; 1975 Jun; 228(6):1757-65. PubMed ID: 50744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of platelet aggregation induced by human breast carcinoma and its inhibition by snake venom peptides, trigramin and rhodostomin.
    Chiang HS; Swaim MW; Huang TF
    Breast Cancer Res Treat; 1995 Mar; 33(3):225-35. PubMed ID: 7749150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on tumor-cell-induced platelet aggregation in human lung cancer cell lines.
    Heinmöller E; Weinel RJ; Heidtmann HH; Salge U; Seitz R; Schmitz I; Müller KM; Zirngibl H
    J Cancer Res Clin Oncol; 1996; 122(12):735-44. PubMed ID: 8954171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of thrombin in ADP-induced platelet aggregation and release: a critical evaluation.
    Macfarlane DE; Walsh PN; Mills DC; Holmsen H; Day HJ
    Br J Haematol; 1975 Aug; 30(4):457-63. PubMed ID: 811245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of platelet aggregation by bovine endocardial apyrase.
    Yi FX; Huang SL; Guo X; Sun P; Guo ZG
    Zhongguo Yao Li Xue Bao; 1999 Sep; 20(9):851-4. PubMed ID: 11245096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro interaction between cultured cells and human blood platelets.
    Holme R; Oftebro R; Hovig T
    Thromb Haemost; 1978 Aug; 40(1):89-102. PubMed ID: 725854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidation of flow-mediated tumour cell-induced platelet aggregation using an ultrasound standing wave trap.
    Bazou D; Santos-Martinez MJ; Medina C; Radomski MW
    Br J Pharmacol; 2011 Apr; 162(7):1577-89. PubMed ID: 21182493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protracted treatment with phorbol ester modulates J-7 human hepatoma-cell-induced aggregation and coagulation of human platelet-rich plasma.
    Ko FN; Yu SM; Teng CM
    Int J Cancer; 1994 Dec; 59(5):706-11. PubMed ID: 7960244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
    Jurasz P; Sawicki G; Duszyk M; Sawicka J; Miranda C; Mayers I; Radomski MW
    Cancer Res; 2001 Jan; 61(1):376-82. PubMed ID: 11196190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.